Programmed Cell Death Protein 1 Blockade Reduces Glycogen Synthase Kinase 3β Activity and Tau Hyperphosphorylation in Alzheimer’s Disease Mouse Models. The gene discussed is PDCD1; the disease is early-onset autosomal dominant Alzheimer disease.